Koss-Olinger Consulting’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22K | Hold |
10,000
| – | – | ﹤0.01% | 314 |
|
|
2025
Q1 | $12K | Hold |
10,000
| – | – | ﹤0.01% | 307 |
|
|
2024
Q4 | $13K | Hold |
10,000
| – | – | ﹤0.01% | 184 |
|
|
2024
Q3 | $34K | Hold |
10,000
| – | – | ﹤0.01% | 271 |
|
|
2024
Q2 | $47K | Buy |
+10,000
| New | +$47K | ﹤0.01% | 259 |
|
|
2024
Q1 | – | Sell |
-10,000
| Closed | -$101K | – | 116 |
|
|
2023
Q4 | $101K | Hold |
10,000
| – | – | 0.01% | 305 |
|
|
2023
Q3 | $78K | Hold |
10,000
| – | – | 0.01% | 267 |
|
|
2023
Q2 | $82K | Hold |
10,000
| – | – | 0.01% | 275 |
|
|
2023
Q1 | $73K | Buy |
+10,000
| New | +$73K | 0.01% | 255 |
|
|
2021
Q3 | – | Sell |
-32,100
| Closed | -$1.82M | – | 248 |
|
|
2021
Q2 | $1.82M | Hold |
32,100
| – | – | 0.27% | 41 |
|
|
2021
Q1 | $1.35M | Buy |
+32,100
| New | +$1.35M | 0.23% | 48 |
|